Combination Using Magnetic Iron Oxide Nanoparticles and Magnetic Field for Cancer Therapy
Wenjun Sun,
No information about this author
Xiaoxia Chai,
No information about this author
Yuan Zhang
No information about this author
et al.
The Chemical Record,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 28, 2024
Abstract
Iron
oxide
nanoparticles
(MNPs)
demonstrate
notable
benefits
in
magnetic
induction,
attributed
to
their
distinctive
physical
and
chemical
attributes.
Emerging
cancer
treatment
utilizing
fields
have
also
gathered
increasing
attention
the
biomedical
field.
However,
defects
of
difficult
dispersion
poor
biocompatibility
MNPs
seriously
hinder
application.
In
order
overcome
its
inherent
maximize
therapeutic
potential
MNPs,
various
functionalized
been
developed,
numerous
combined
methods
based
on
widely
studied.
this
review,
we
compare
analyze
common
with
different
sizes,
shapes,
functional
modifications.
Additionally,
introduced
mechanisms
strategies,
such
as
magnetically
controlled
targeting,
hyperthermia,
magneto‐mechanical
effect,
which
unique
induction
capabilities
MNPs.
Finally,
main
challenges
smart
nanomaterials
were
discussed.
This
review
seeks
offer
a
thorough
overview
biomedicine
new
sight
for
application
tumor
treatment.
Language: Английский
Iron oxide nanoparticles: a versatile nanoplatform for the treatment and diagnosis of ovarian cancer
Neelam Poonia,
No information about this author
Vipan Kumar,
No information about this author
Rudra Narayan Subudhi
No information about this author
et al.
Therapeutic Delivery,
Journal Year:
2024,
Volume and Issue:
unknown, P. 1 - 14
Published: Dec. 26, 2024
Ovarian
cancer
remains
one
of
the
main
causes
human
mortality,
accounting
for
millions
deaths
every
year.
Despite
several
clinical
options
such
as
chemotherapy,
photodynamic
therapy
(PDT),
hormonal
treatment,
radiation
therapy,
and
surgery
to
manage
this
disease,
mortality
rate
is
still
very
high.
This
alarming
statistic
highlights
urgent
need
innovative
approaches
improve
both
diagnosis
treatment.
Success
stories
iron
oxide
nanoparticles,
i.e.
Ferucarbotran
(Resovist®)
Ferrixan
(Cliavist®)
liver
imaging,
CNS
(Central
nervous
system)
cell
labeling,
etc.
have
motivated
researchers
explore
these
nanocarriers
treatment
different
diseases.
Iron
nanoparticles
improved
therapeutic
efficacy
anticancer
drugs
through
targeted
delivery,
heat/ROS
(reactive
oxygen
species)
generation
on
application
external
energy
also
shown
great
potential
contrast
agents
magnetic
resonance
imaging
(MRI).
Their
unique
properties
enable
sensitive
surface
modification
allows
attachment
specific
biomolecules
detection
ovarian
cells.
properties,
viz.
responsiveness
functionalization,
make
them
versatile
tools
enhancing
outcomes.
Present
article
reviews
literature
synthesis,
applications
in
management
cancer.
Language: Английский
Bio-intelligent plasma-engineered diferuloylmethane/fucoidan/neutrophil lysate/iron oxide nanoclusters for phototherapeutic and magnetotherapeutic with in situ magnetic gelation mitigating inflammatory diseases
Andrew E.‐Y. Chuang,
No information about this author
Yung-Wei Lin,
No information about this author
Pei‐Ru Jheng
No information about this author
et al.
Colloids and Surfaces B Biointerfaces,
Journal Year:
2024,
Volume and Issue:
243, P. 114054 - 114054
Published: July 4, 2024
Language: Английский
Light‐Driven Green‐Fabricated Artificial Intelligence‐Enabled Micro/Nanorobots for Multimodal Phototherapeutic Management of Bladder Cancer
Chi‐Hung Hsiao,
No information about this author
Yung‐Wei Lin,
No information about this author
Chia‐Hung Liu
No information about this author
et al.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 29, 2024
Abstract
Combination
therapy
based
on
precise
phototherapies
combined
with
immune
modulation
provides
successful
antitumor
effects.
In
this
study,
a
combination
is
designed
phototactic,
photosynthetic,
and
phototherapeutic
Chlamydomonas
Reinhardtii
(CHL)‐glycol
chitosan
(GCS)‐polypyrrole
(PPy)
nanoparticle
(NP)‐enhanced
immunity
the
tumor
microenvironment
turnover
of
cytotoxic
T
cells
M1/M2
macrophages,
which
photothermal
GCS‐PPy
NPs
decorated
onto
phototactic
photosynthetic
CHL.
Phototherapy
CHL‐GCS‐PPy
alleviates
hypoxia
modulates
microenvironment,
induces
cell
death.
particular,
response
potent
memory
induced
by
combining
self‐navigated
significantly
alleviate
progression
bladder
cancer
in
C57BL/6
mice
effectively
inhibit
growth.
Furthermore,
they
also
potentially
prevent
recurrence,
promising
therapeutic
strategy
for
clinical
therapy.
Language: Английский
A novel water-soluble polymer nanocomposite containing ultra-small Fe3O4 nanoparticles with strong antibacterial and antibiofilm activity
Nanoscale,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 2, 2024
A
novel
water-soluble
polymer
nanocomposite
with
ultra-small
iron
oxide
nanoparticles
intercalated
into
a
biocompatible
matrix
of
1-vinyl-1,2,4-triazole
and
N
-vinylpyrrolidone
copolymer
exhibits
pronounced
antibacterial
antibiofilm
activity.
Language: Английский
Spermatozoon-propelled microcellular submarines combining innate magnetic hyperthermia with derived nanotherapies for thrombolysis and ischemia mitigation
Pei-Wei Weng,
No information about this author
Chia‐Hung Liu,
No information about this author
Pei-Ru Jheng
No information about this author
et al.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Aug. 8, 2024
Abstract
Thrombotic
cardiovascular
diseases
are
a
prevalent
factor
contributing
to
both
physical
impairment
and
mortality.
Thrombolysis
ischemic
mitigation
have
emerged
as
leading
contemporary
therapeutic
approaches
for
addressing
the
consequences
of
injury
reperfusion
damage.
Herein,
an
innovative
cellular-cloaked
spermatozoon-driven
microcellular
submarine
(SPCS),
comprised
multimodal
motifs,
was
designed
integrate
nano-assembly
thrombolytics
with
immunomodulatory
ability
derived
from
innate
magnetic
hyperthermia.
Rheotaxis-based
navigation
utilized
home
cross
clot
barrier,
finally
accumulate
in
vascular
organs,
where
thrombolytic
motif
“switched-on”
by
action
thrombus
red
blood
cell-driven
In
murine
model,
SPCS
system
combining
hyperthermia
demonstrated
capacity
augment
delivery
efficacy,
produce
nanotherapeutic
outcomes,
exhibit
potent
activity,
ameliorate
tissue
These
findings
underscore
multifaceted
potential
our
approach,
offering
ischemia-mitigating
effects.
Given
its
extended
effects
thrombus-targeting
capability,
this
biocompatible
holds
promise
agent
enhancing
efficacy
preventing
risks
after
managing
thrombosis.
Graphical
abstract
Language: Английский